Old Web
English
Sign In
Acemap
>
authorDetail
>
Sophie Le Pogam
Sophie Le Pogam
Genentech
Hepatitis C virus
Hepatitis C
Hepacivirus
Medicine
Virology
4
Papers
43
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients
2019
Infectious Diseases and Therapy
Essack Mitha
Gergely Kriván
Frédérique Jacobs
Arnon Nagler
Sally Alrabaa
Analia Mykietiuk
Andrew Kenwright
Sophie Le Pogam
Barry Clinch
Loreta Vareikiene
Show All
Source
Cite
Save
Citations (9)
Interferon‐free regimens containing setrobuvir for patients with genotype 1 chronic hepatitis C: a randomized, multicenter study
2016
Liver International
Donald M. Jensen
Michael J. Brunda
Robert Elston
Edward Gane
Jacob George
Katerina Glavini
Janet Hammond
Sophie Le Pogam
Isabel Najera
Sharon Passe
Anna Piekarska
Ignacio Rodriguez
Stefan Zeuzem
Tom Chu
Show All
Source
Cite
Save
Citations (11)
Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis.
2016
Journal of Gastroenterology and Hepatology
Jia-Horng Kao
Shui‐Yi Tung
Youn Jae Lee
Satawat Thongsawat
Tawesak Tanwandee
I.-Shyan Sheen
Jinzi J. Wu
Hui Li
Barbara J. Brennan
Julian Zhou
Sophie Le Pogam
Isabel Najera
James Thommes
George Hill
Show All
Source
Cite
Save
Citations (7)
Similar Prevalence of Low-Abundance Drug-Resistant Variants in Treatment-Naive Patients with Genotype 1a and 1b Hepatitis C Virus Infections as Determined by Ultradeep Pyrosequencing
2014
PLOS ONE
Severine Margeridon-Thermet
Sophie Le Pogam
Lewyn Li
Tommy F. Liu
Nancy S. Shulman
Robert W. Shafer
Isabel Najera
Show All
Source
Cite
Save
Citations (16)
1